欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:Generation of tumor-targeted human T lymphocytes from induc

发布时间:2026-01-06

Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy

Maria Themeli,  Christopher C Kloss,  Giovanni Ciriello,  Victor D Fedorov,  Fabiana Perna, Mithat Gonen  & Michel Sadelain

Progress in adoptive T-cell therapy for cancer and infectious diseases1, 2 is hampered by the lack of readily available, antigen-specific, human T lymphocytes. Pluripotent stem cells could provide an unlimited source of T lymphocytes, but the therapeutic potential of human pluripotent stem cell–derived lymphoid cells generated to date remains uncertain3, 4, 5, 6. Here we combine induced pluripotent stem cell (iPSC)7 and chimeric antigen receptor (CAR)8 technologies to generate human T cells targeted to CD19, an antigen expressed by malignant B cells, in tissue culture. These ipsC-derived, CAR-expressing T cells display a phenotype resembling that of innate γδ T cells. Similar to CAR-transduced, peripheral blood γδ T cells, the ipsC–derived T cells potently inhibit tumor growth in a xenograft model. This approach of generating therapeutic human T cells 'in the dish' may be useful for cancer immunotherapy and other medical applications.

 

上一篇:D311 (703)弱碱性丙烯酰胺型多孔阴离子交换树脂
下一篇:西亚试剂:调控餐后血脂运输和血糖平衡的重要蛋白
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4